Is there a generic for Chlorprothixene?

The FDA Orange Book does not currently list an approved generic (ANDA) for Chlorprothixene. It is available as 3 brand (NDA) applications.

What is the reference-listed drug for Chlorprothixene?

TARACTAN (NDA 016149, ROCHE) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Chlorprothixene are approved?

Chlorprothixene is approved in the following dosage forms: concentrate, injectable, tablet.

FDA Orange Book · active-ingredient family

Chlorprothixene

Chlorprothixene is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:TARACTAN · NDA 016149

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · concentrate, injectable, tablet

Product	Applicant	Application	TE	Approved
TARACTAN	ROCHE	NDA 016149	—	Approved Prior to Jan 1, 1982
TARACTAN	ROCHE	NDA 012487	—	Approved Prior to Jan 1, 1982
TARACTAN×4	ROCHE	NDA 012486	—	Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Chlorprothixene — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo